查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1563919

全球细胞分选市场

Cell Sorting
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年全球细胞分选市场将达16亿美元

预计 2023 年全球细胞分选市场规模为 8.692 亿美元，预计到 2030 年将达到 16 亿美元，在 2023-2030 年分析期间复合年增长率为 9.2%。细胞分选机组件是本报告分析的细分市场之一，预计复合年增长率为 9.9%，到分析期结束时将达到 8.62 亿美元。分析期间，试剂和消耗品领域的复合年增长率预计为 9.1%。

美国市场预估价值2.411亿美元，中国预期复合年增长率为8.5%

预计 2023 年美国细胞分选市场规模将达 2.411 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 2.439 亿美元，2023-2030 年分析期间复合年增长率为 8.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 8.6% 和 7.3%。在欧洲，德国预计复合年增长率为 7.3%。

全球细胞分选市场－主要趋势与驱动因素总结

细胞分选如何彻底改变生物医学研究与临床应用？

细胞分选是生物医学研究和临床应用中的重要技术，使科学家和临床医生能够根据其独特的特征从异质混合物中分离出特定的细胞群。这个过程对于增加我们对细胞生物学、疾病机制和治疗方法发展的理解至关重要。细胞分选技术，例如萤光激活细胞分选（FACS）和磁激活细胞分选（MACS），可以根据细胞大小、形态、蛋白质表达和萤光标记物来分离细胞，从而可以根据细胞的大小、形态、蛋白质表现和萤光标记来分离细胞。在研究中，细胞分选在免疫学、肿瘤学和干细胞生物学等领域中扮演重要角色。例如，分离免疫细胞以研究它们对感染疾病和治疗的反应，或对癌细胞进行基因分析以更好地了解肿瘤进展和抗药性。在临床应用中，细胞分选对于骨髓移植和基于细胞的治疗方法的生产等过程至关重要，在这些过程中必须分离纯的治疗细胞群以确保疗效和安全性。随着细胞分选技术的进步，它在基础科学和治疗创新方面不断取得突破。

为什么细胞分选对于开发细胞治疗方法至关重要？

细胞分选对于免疫疗法和再生医学等以细胞为基础的治疗方法的开发尤其重要。在 CAR-T 细胞疗法等治疗中，从患者的血液中提取免疫细胞，对其进行基因改造以靶向癌细胞，进行扩增，然后重新註入患者体内。这种治疗的成功取决于准确分选和分离 T 细胞的能力，并确保只使用那些能够靶向肿瘤的细胞。同样，干细胞疗法使用分选技术从骨髓等组织中精製干细胞群。透过先进的分选技术确保高纯度和存活的细胞群对于这些治疗的安全性和有效性至关重要。除了在治疗发展中的作用之外，细胞分选技术还用于透过分离和分析特定的免疫细胞和癌细胞来监测患者对治疗的反应。这种能力是优化治疗计画和改善治疗结果的关键，使细胞分选成为推动个人化医疗的重要工具。

技术创新如何改善细胞分选技术？

技术进步极大地提高了细胞分选技术的准确性、速度和可扩展性，使其在研究和临床应用中更有效。该领域最重要的创新之一是开发高通量自动分选系统，该系统可以在最少的人工干预下处理大量样本。此类系统在药物研究和临床试验中特别有用，其中需要快速分析和分类大量细胞样本，以推进药物开发和患者诊断。基于微流体的分选技术也正在彻底改变该领域，允许在高度小型化的环境中精确控制单一细胞。这种方法最大限度地减少了分选过程中对细胞的损害，并提高了分选群体的纯度和活力。这在干细胞治疗和癌症治疗等敏感应用中尤其重要。无标定细胞分选技术，例如基于介电泳和声波的技术，正在成为依赖萤光或磁性标记的传统方法的有力替代品。这些新技术保留了细胞完整性并允许更准确的下游分析。此外，人工智慧和机器学习的进步已整合到分选平台中，以优化分选过程中的决策，从而更有效地分离目标细胞并减少错误。

细胞分选市场的主要成长动力是什么？

细胞分选市场的成长是由多种因素推动的，例如对细胞疗法的需求不断增长、生物技术的进步以及研究和临床环境中对高精度细胞分析的需求不断增长。特别是，CAR-T细胞疗法的发展需要基因改造和分离特定免疫细胞用于治疗用途。随着越来越多的细胞疗法进入临床，对可靠且扩充性的细胞分选技术的需求不断增长。基于微流体的自动化分选系统等技术创新使各种规模的实验室更容易且更有效率地进行细胞分选，进一步推动市场成长。此外，对个人化医疗的日益关注正在推动对细胞分选的需求。细胞分选能够分离和分析患者特异性细胞，从而能够根据个别细胞概况开发标靶治疗。单细胞分析的兴起也促进了细胞分选市场的成长，单细胞分析需要分选和分离单一细胞以进行详细的分子研究。此外，癌症和自体免疫疾病等慢性疾病的日益流行，增加了对先进细胞分选技术的需求，以支持新诊断和治疗方法的开发。随着对生命科学研究的持续投资和研究技术的进步，细胞分选市场预计在未来几年将出现强劲成长。

调查企业举例（共21家）

  • Affymetrix, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cytonome/St, LLC
  • Miltenyi Biotec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Sony Biotechnology Inc.
  • Sysmex Partec GmbH
  • Union Biometrica, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10951

Global Cell Sorting Market to Reach US$1.6 Billion by 2030

The global market for Cell Sorting estimated at US$869.2 Million in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2023-2030. Cell Sorters Component, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis period. Growth in the Reagents & Consumables Component segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.1 Million While China is Forecast to Grow at 8.5% CAGR

The Cell Sorting market in the U.S. is estimated at US$241.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$243.9 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global Cell Sorting Market - Key Trends and Drivers Summarized

How Is Cell Sorting Revolutionizing Biomedical Research and Clinical Applications?

Cell sorting is a critical technique in both biomedical research and clinical applications, allowing scientists and clinicians to separate specific cell populations from heterogeneous mixtures based on their unique characteristics. This process is essential for advancing our understanding of cellular biology, disease mechanisms, and therapeutic development. Cell sorting technologies, such as Fluorescence-Activated Cell Sorting (FACS) and Magnetic-Activated Cell Sorting (MACS), have made it possible to isolate cells based on size, morphology, protein expression, or fluorescent markers, enabling precise analysis of specific cell types. In research, cell sorting plays a crucial role in fields like immunology, oncology, and stem cell biology. For instance, it allows scientists to isolate immune cells to study their behavior in response to infection or therapy, or to sort cancer cells for genetic profiling to better understand tumor progression and drug resistance. In clinical applications, cell sorting is indispensable in procedures like bone marrow transplants and in the manufacturing of cell-based therapies, where pure populations of therapeutic cells must be isolated to ensure effectiveness and safety. As cell sorting technologies advance, they continue to drive breakthroughs in both basic science and therapeutic innovation.

Why Is Cell Sorting Essential for the Development of Cell-Based Therapies?

Cell sorting is integral to the development of cell-based therapies, particularly in areas such as immunotherapy and regenerative medicine. In therapies like CAR-T cell treatment, immune cells are extracted from a patient’s blood, genetically modified to target cancer cells, expanded, and then reinfused into the patient. The success of this therapy depends on the precise sorting and isolation of T cells, ensuring that only the cells capable of targeting tumors are used. Similarly, in stem cell therapies, sorting technologies are used to purify stem cell populations from tissues such as bone marrow, which can then be used to regenerate damaged tissues or treat degenerative diseases. Ensuring high-purity, viable cell populations through advanced sorting techniques is critical for the safety and efficacy of these therapies, as contamination with unwanted cell types can lead to adverse reactions or ineffective treatment. Beyond their role in treatment development, cell sorting technologies are also used to monitor patient responses to therapies by isolating specific immune or tumor cells for analysis. This capability is key for optimizing treatment plans and improving therapeutic outcomes, making cell sorting an essential tool in the advancement of personalized medicine.

How Are Technological Innovations Enhancing Cell Sorting Techniques?

Technological advancements are dramatically improving the accuracy, speed, and scalability of cell sorting techniques, making them more effective for both research and clinical applications. One of the most significant innovations in this space is the development of high-throughput, automated sorting systems that can process large sample volumes with minimal human intervention. These systems are particularly useful in pharmaceutical research and clinical trials, where large numbers of cell samples need to be analyzed and sorted quickly to advance drug development or patient diagnostics. Microfluidic-based sorting technologies are also revolutionizing the field, offering precise control over individual cells in a highly miniaturized environment. This approach minimizes the damage to cells during the sorting process and improves the purity and viability of the sorted populations, which is especially important in sensitive applications like stem cell therapy and cancer treatment. Label-free cell sorting techniques, such as those based on dielectrophoresis or acoustic waves, are emerging as powerful alternatives to traditional methods that rely on fluorescent or magnetic labeling. These new technologies preserve cell integrity, enabling more accurate downstream analyses. Furthermore, advances in artificial intelligence and machine learning are being integrated into sorting platforms to optimize decision-making during the sorting process, leading to more efficient isolation of target cells and reducing errors.

What Are the Key Growth Drivers in the Cell Sorting Market?

The growth in the cell sorting market is driven by several factors, including the rising demand for cell-based therapies, advancements in biotechnology, and the increasing need for high-precision cell analysis in both research and clinical settings. One of the primary drivers is the expanding use of cell sorting in immunotherapy, particularly in the development of CAR-T cell therapies, which require the isolation of specific immune cells for genetic modification and therapeutic use. As more cell-based therapies enter clinical practice, the need for reliable and scalable cell sorting technologies continues to grow. Technological innovations, such as automated and microfluidic-based sorting systems, are further propelling market growth by making cell sorting more accessible and efficient for laboratories of all sizes. Additionally, the increasing focus on personalized medicine is fueling demand for cell sorting, as it allows for the isolation and analysis of patient-specific cells, enabling the development of targeted treatments based on individual cellular profiles. The rise of single-cell analysis, which requires the sorting and isolation of individual cells for detailed molecular studies, is also contributing to the growth of the cell sorting market. Furthermore, the growing prevalence of chronic diseases, such as cancer and autoimmune disorders, is driving demand for advanced cell sorting technologies that can support the development of new diagnostics and treatments. With continued investment in life sciences research and the advancement of sorting technologies, the cell sorting market is expected to experience robust growth in the coming years.

Select Competitors (Total 21 Featured) -

  • Affymetrix, Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cytonome/St, LLC
  • Miltenyi Biotec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Sony Biotechnology Inc.
  • Sysmex Partec GmbH
  • Union Biometrica, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Sorting - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Expands Market for Cell Sorting Technologies
    • Advancements in Microfluidics Propel Growth in Automated Cell Sorting
    • Increasing Use of Fluorescence-Activated Cell Sorting (FACS) Drives Adoption in Research and Therapeutics
    • Growing Focus on Single-Cell Genomics Strengthens Demand for High-Precision Cell Sorting
    • Technological Innovations in Label-Free Sorting Methods Create New Opportunities in Cell Sorting
    • Expansion of Immunotherapy Boosts Demand for Efficient Cell Sorting Solutions
    • Rising Investment in Stem Cell Research Propels Growth in Cell Sorting Applications
    • Increased Focus on Rare Cell Populations Drives Innovation in Cell Sorting Techniques
    • Growing Use of Cell Sorting in Biopharmaceutical Production Fuels Market Expansion
    • Advances in Magnetic-Activated Cell Sorting (MACS) Enhance Efficiency in Cell Isolation and Sorting
    • Automation and High-Throughput Sorting Systems Boost Efficiency in Research and Clinical Workflows
    • Increased Use of Cell Sorting in Drug Discovery Expands Market for Innovative Sorting Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Sorting Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Sorters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Sorters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cell Sorters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fluorescence-based Droplet Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fluorescence-based Droplet Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Fluorescence-based Droplet Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Magnetic-activated Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Magnetic-activated Cell Sorting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Magnetic-activated Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for MEMS-Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for MEMS-Microfluidics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for MEMS-Microfluidics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Medical Schools & Academic Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Medical Schools & Academic Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Medical Schools & Academic Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • JAPAN
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • CHINA
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • EUROPE
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cell Sorting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cell Sorting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Cell Sorting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • FRANCE
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • GERMANY
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cell Sorting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Cell Sorting by Component - Cell Sorters, Reagents & Consumables and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Cell Sorting by Component - Percentage Breakdown of Value Sales for Cell Sorters, Reagents & Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Cell Sorting by Technology - Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Cell Sorting by Technology - Percentage Breakdown of Value Sales for Fluorescence-based Droplet Cell Sorting, Magnetic-activated Cell Sorting and MEMS-Microfluidics for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Cell Sorting by End-Use - Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Cell Sorting by End-Use - Percentage Breakdown of Value Sales for Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies and Hospitals & Clinical Testing Laboratories for the Years 2014, 2024 & 2030

IV. COMPETITION